| Cat.No. | Name | Information |
|---|---|---|
| M54004 | α-CGRP(human) | α-CGRP(human) is a regulatory neuropeptide of 37 amino acids. |
| M53900 | Adrenomedullin (AM) (22-52), human | Adrenomedullin (AM) (22-52), human is an adrenomedullin receptor antagonist, and also antagonizes the calcitonin generelated peptide (CGRP) receptor in the hindlimb vascular bed of the cat. |
| M53228 | α-CGRP (mouse, rat) | α-CGRP (mouse, rat), a neuropeptide (calcitonin gene-related peptide (CGRP)) mainly expressed in neuromuscular junction, is a potent vasodilator. |
| M53225 | β-CGRP, human | β-CGRP, human (Human β-CGRP) is one of calcitonin peptides, with IC50s of 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP2 in cells. |
| M40804 | Rimegepant Sulfate | Rimegepant Sulfate is a potent, selective, competitive, orally active calcitonin gene-related peptide (CGRP) antagonist with a Ki of 0.027 nM.May be used in migraine-related studies. |
| M40614 | Calcitonin (human) | Calcitonin (human) is a calcitonin that lowers blood calcium levels and inhibits bone resorption and may be used in studies related to hypercalcemia or osteoporosis. |
| M28370 | Cagrilintide acetate | Cagrilintide acetate is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity. |
| M28198 | Vazegepant | Vazegepant (Zavegepant) is a first-in-class CGRP receptor antagonist with potential for acute studies in migraine. |
| M25531 | α-CGRP, human TFA | α-CGRP, human TFA is a regulatory neuropeptide of 37 amino acids. α-CGRP, human TFA can be used as a potent vasodilator. |
| M24721 | Erenumab | Erenumab is a first-in-class fully human monoclonal CGRP antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the research of episodic migraine. |
| M22520 | Galcanezumab | Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. |
| M13935 | Rat CGRP-(8-37) | Rat CGRP-(8-37) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) is a highly selective CGRP receptor antagonist. |
| M13933 | MK-3207 | MK-3207 is a potent and orally bioavailable CGRP receptor antagonist (IC50= 0.12 nM; Ki= 0.024 nM); highly selective versus human AM1, AM2, CTR, and AMY3. |
| M13932 | HCGRP-(8-37) | HCGRP-(8-37) is a human calcitonin gene-related peptide (hCGRP) fragment and also an antagonist of CGRP receptor. |
| M13931 | Calcitonin Gene Related Peptide (CGRP) (83-119), rat TFA | Calcitonin Gene Related Peptide (CGRP) (83-119), rat (TFA) is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor (CRLR). |
| M10894 | Ubrogepant | Ubrogepant (MK-1602) is a novel oral calcitonin gene-associated peptide receptor (CGRP) antagonist with the potential to be used in acute migraine studies. |
| M10801 | Calcitonin (salmon) | Calcitonin salmon is a calcium-regulating hormone that is a dual agonist of amylin and calcitonin receptors that stimulate bone production and inhibit bone resorption. |
| M10785 | Atogepant | Atogepant (MK-8031) is an orally active and selective calcitonin gene–related peptide receptor (CGRP) antagonist. Atogepant can be used for the research of migraine. |
| M10372 | Vazegepant hydrochloride | Vazegepant (BHV-3500) hydrochloride is a first-in-class, high affinity CGRP receptor antagonist (hCGRP Ki= 0.023 nM). Vazegepant hydrochloride may be useful in the effective treatment of lung inflammation associated with COVID-19. |
| M9165 | Rimegepant | Rimegepant, also known as BMS-927711, is a potent, selective, competitive, and orally active calcitonin gene-related peptide (CGRP) antagonist with a Ki value of 0.027 nM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
